New ultrasound method for diagnosing breast tumors
3D Multimodal Ultrasound Imaging for Breast Cancer
This study tests a new 3D ultrasound method to see if it can better diagnose breast tumors in women compared to traditional imaging techniques.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 125 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT04692818 on ClinicalTrials.gov |
What this trial studies
This research investigates the effectiveness of a novel 3D ultrasound imaging technique for diagnosing breast masses. The study utilizes advanced ultrasound technology, including the GE Logiq E10 clinical ultrasound scanner and the Verasonics research scanner, to enhance imaging quality and accuracy. Adult women with solid breast lesions will be evaluated to determine the diagnostic capabilities of this new method compared to traditional imaging techniques.
Who should consider this trial
Good fit: Ideal candidates for this study are adult women aged 18 and older with solid breast lesions measuring 3mm or larger.
Not a fit: Patients who are under 18 years of age, pregnant, lactating, or currently receiving cancer therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and earlier diagnosis of breast tumors, improving patient outcomes.
How similar studies have performed: Other studies have shown promising results with advanced ultrasound imaging techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult women ≥ 18 years of age. * solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other IRB-approved studies) * lesion size of 3mm or larger Exclusion Criteria: * \< 18 years of age. * Lacking capacity to consent * Pregnant or lactating * Receiving cancer therapy such as chemotherapy or radiation therapy
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Shigao Chen, PhD — Mayo Clinic
- Study coordinator: Bobbie Ott
- Email: Ott.Bobbie@mayo.edu
- Phone: 507-293-0922
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.